On the other hand, inserting the ERβ gene in the SW620 metastatic CRC cells showed no effects on MYC and miRNAs [108], suggesting that E2 treatment following ERβ activation could be more beneficial for preventing and/or treatment of early stage, but not advanced stages, colon cancers. This evidence concerns the gene ESR2 and malignant colon neoplasm.